Management of behavioural and psychological symptoms of dementia: a pragmatic scoping review of European guidelines and literature.

IF 3.5 3区 医学 Q2 GERIATRICS & GERONTOLOGY
Alessandra Coin, Elsa Brew-Girard, Ellen Tracey, Vincenza Frisardi, Federica Piccione, Costanza Muraro, Eleonora Mizzon, Susan D Shenkin, Pinar Soysal, Tomas Welsh, Hanna-Maria Roitto
{"title":"Management of behavioural and psychological symptoms of dementia: a pragmatic scoping review of European guidelines and literature.","authors":"Alessandra Coin, Elsa Brew-Girard, Ellen Tracey, Vincenza Frisardi, Federica Piccione, Costanza Muraro, Eleonora Mizzon, Susan D Shenkin, Pinar Soysal, Tomas Welsh, Hanna-Maria Roitto","doi":"10.1007/s41999-025-01155-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Dementia prevalence within the European Union (EU) is expected to double by 2050. Behavioural and Psychological Symptoms of Dementia (BPSD) are common, causing burden to patients and caregivers. This pragmatic scoping review aims to synthesize recommendations of European BPSD management guidelines and literature, highlighting areas of consensus and disagreement.</p><p><strong>Methods: </strong>An electronic literature search, including Medline, PsychINFO, and CINAHL, and Internet search for grey literature were undertaken to identify published BPSD guidelines from the EU, European Economic Area (EEA) and UK, supplemented by contacting EU member countries of European Geriatric Medicine Society (EuGMS).</p><p><strong>Results: </strong>The literature search found 11 papers describing BPSD management. Of the 32 countries of interest, 22 guidelines were sourced (five confirmed no guidelines, five did not respond). There was a general consensus between the guidelines, as all recommended comprehensive assessment and individualised approaches, with non-pharmacological therapies as first line, but there was disagreement around specific therapies. Psycho-education was most commonly recommended (15 countries). There was general agreement that pharmacological treatment should be used as an adjunct to non-pharmacological interventions, but recommendations differed between medication groups. Short-term atypical antipsychotics were most commonly recommended, especially risperidone (18 countries). 15 countries recommended acetylcholinesterase inhibitors and 12 memantine. 16 countries recommended the use of SSRIs. Recommendations for the use of sedative medications and antiepileptics varied.</p><p><strong>Conclusions: </strong>This study provides a broad, inclusive overview of current European guidelines for the management of BPSD, demonstrating significant variability. Clinical practice in dementia care throughout Europe needs to be optimised and standardised.</p>","PeriodicalId":49287,"journal":{"name":"European Geriatric Medicine","volume":" ","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Geriatric Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s41999-025-01155-6","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Dementia prevalence within the European Union (EU) is expected to double by 2050. Behavioural and Psychological Symptoms of Dementia (BPSD) are common, causing burden to patients and caregivers. This pragmatic scoping review aims to synthesize recommendations of European BPSD management guidelines and literature, highlighting areas of consensus and disagreement.

Methods: An electronic literature search, including Medline, PsychINFO, and CINAHL, and Internet search for grey literature were undertaken to identify published BPSD guidelines from the EU, European Economic Area (EEA) and UK, supplemented by contacting EU member countries of European Geriatric Medicine Society (EuGMS).

Results: The literature search found 11 papers describing BPSD management. Of the 32 countries of interest, 22 guidelines were sourced (five confirmed no guidelines, five did not respond). There was a general consensus between the guidelines, as all recommended comprehensive assessment and individualised approaches, with non-pharmacological therapies as first line, but there was disagreement around specific therapies. Psycho-education was most commonly recommended (15 countries). There was general agreement that pharmacological treatment should be used as an adjunct to non-pharmacological interventions, but recommendations differed between medication groups. Short-term atypical antipsychotics were most commonly recommended, especially risperidone (18 countries). 15 countries recommended acetylcholinesterase inhibitors and 12 memantine. 16 countries recommended the use of SSRIs. Recommendations for the use of sedative medications and antiepileptics varied.

Conclusions: This study provides a broad, inclusive overview of current European guidelines for the management of BPSD, demonstrating significant variability. Clinical practice in dementia care throughout Europe needs to be optimised and standardised.

痴呆的行为和心理症状的管理:对欧洲指南和文献的实用范围审查。
目的:预计到2050年,欧盟(EU)内的痴呆症患病率将翻一番。痴呆症的行为和心理症状(BPSD)很常见,给患者和护理人员造成负担。这一务实的范围审查旨在综合欧洲BPSD管理指南和文献的建议,突出共识和分歧的领域。方法:通过Medline、PsychINFO、CINAHL等电子文献检索和灰色文献网络检索,确定欧盟、欧洲经济区(EEA)和英国已发表的BPSD指南,并联系欧洲老年医学学会(EuGMS)欧盟成员国。结果:文献检索共找到11篇描述BPSD管理的论文。在感兴趣的32个国家中,有22个提供了指南(5个确认没有指南,5个没有回应)。指南之间有一个普遍的共识,所有指南都推荐综合评估和个体化方法,以非药物治疗为一线,但在具体治疗方面存在分歧。心理教育是最常被推荐的(15个国家)。普遍认为药物治疗应作为非药物干预的辅助手段,但不同用药组的建议不同。短期非典型抗精神病药物最常被推荐,尤其是利培酮(18个国家)。15个国家推荐乙酰胆碱酯酶抑制剂,12个国家推荐美金刚。16个国家建议使用ssri类药物。镇静药物和抗癫痫药物的使用建议各不相同。结论:本研究对当前欧洲BPSD管理指南进行了广泛、全面的概述,显示出显著的可变性。整个欧洲的痴呆症护理临床实践需要优化和标准化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
European Geriatric Medicine
European Geriatric Medicine GERIATRICS & GERONTOLOGY-
CiteScore
6.70
自引率
2.60%
发文量
114
审稿时长
6-12 weeks
期刊介绍: European Geriatric Medicine is the official journal of the European Geriatric Medicine Society (EUGMS). Launched in 2010, this journal aims to publish the highest quality material, both scientific and clinical, on all aspects of Geriatric Medicine. The EUGMS is interested in the promotion of Geriatric Medicine in any setting (acute or subacute care, rehabilitation, nursing homes, primary care, fall clinics, ambulatory assessment, dementia clinics..), and also in functionality in old age, comprehensive geriatric assessment, geriatric syndromes, geriatric education, old age psychiatry, models of geriatric care in health services, and quality assurance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信